Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Why is Intel CEO resisting calls for resignation? What drove Ethereum to its highest price since 2021? How will Trump-Putin Alaska summit impact global trade? Why is the Fed considering multiple rate cuts this year? What caused the recent sharp drop in Trade Desk stock? Why are US data centers blamed for rising electric bills? How is Trump’s tariff policy affecting auto industries?

Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

benzinga.com/analyst-stock-ratings/price-target/25/08/46785919/regeneron-pharmaceuticals-likely-to-report-lower-q2-earnings-these-most-accura

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will release earnings results for the second quarter, before the opening bell on Friday, Aug. 1.
Analysts expect the Tarrytown, New York -based company to report quarterly earnings at $8.43 per share, down from $11.56 per share in the…

This story appeared on benzinga.com, 2025-08-01 09:17:18.